Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its OpenAlex record; 1 of the 1 references it cites were found in a registry or an index.

A Critical Review of Cyclosporine Therapy in Inflammatory Bowel Disease

William J. Sandborn·1995·Inflammatory Bowel Diseases

Abstract

Cyclosporine A (CsA) is a potent inhibitor of cell-mediated immunity. Controlled trials in Crohn's disease with low-dose CsA (≤5 mg/kg/day) did not show efficacy for either chronically active inflammatory disease or for maintenance of remission. Uncontrolled trials of high-dose CsA (≥ 5 mg/kg/day oral or 4 mg/kg/day i.v.) suggest efficacy for both inflammatory and fistulous Crohn's disease. Both uncontrolled trials and one controlled study suggest that high-dose CsA is efficacious for severe ulcerative colitis (UC). A controlled trial of low-dose CsA enemas for left-sided UC did not show efficacy. There is a significant theoretical risk of irreversible CsA-associated nephropathy following treatment of inflammatory bowel disease (IBD) with high-dose CsA. Severe infectious complications may also occur rarely. It appears that CsA must be used at relatively high (and potentially toxic) dosages to achieve efficacy in IBD. Future studies should evaluate the efficacy and safety of the short-term use of high-dose CsA as “rescue therapy” in severe inflammatory Crohn's disease and UC, as well as in fistulous Crohn's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1002/ibd.3780010107

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 217

Metadata

Authors
Sandborn, W. J.
Venue
Inflammatory Bowel Diseases
Publisher
Oxford University Press
Published
1995-01-01
Volume
1
Issue
1
Pages
48-63
ISSN
1078-0998 (ISSN-L)
OpenAlex
W2140698597
Cited by
217
References
1
FWCI
7.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Critical Review of Cyclosporine Therapy in Inflammatory Bowel Disease. https://app.cochat.ai/papers/10.1002/ibd.3780010107
The paper
Sandborn, W. J. (1995). A Critical Review of Cyclosporine Therapy in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. https://doi.org/10.1002/ibd.3780010107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.